Antibody titer after administration of mRNA-based vaccine against severe acute respiratory syndrome coronavirus 2 in liver transplant recipients.
Atsuyoshi MitaYasunari OhnoYuichi MasudaKazuki YoshizawaKoji KubotaTsuyoshi NotakeAkira ShimizuHidetoshi MatsunamiYuji SoejimaPublished in: Annals of gastroenterological surgery (2023)
Liver transplant recipients can acquire immunity similar to that of healthy people through vaccination against SARS-CoV-2. The antibody decay rate is the same, and booster vaccinations should be administered similarly to that in healthy individuals.